logo

For the Inventor, By the Inventor

Los Altos Hills, CA, United States of America

Jeffrey J Seilhamer

This inventor holds 55 USPTO granted patents, primarily in Biotechnology Research (CPC class 536 ). Top assignees: Incyte Pharmaceuticals, Inc., Incyte Corporation, Incyte Genomics, Inc.. Active years: 1991-2011.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Jeffrey J Seilhamer. Retrieved from https://idiyas.com/inventor/jeffrey-j-seilhamer

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 55

% Patents Active = 96.4

Average Co-Inventor Count = 3.4

ph-index = 14

Forward Citations = 705(Granted Patents)

Forward Citations (Not Self Cited) = 693(Dec 10, 2025)


Inventors with similar research interests:


Location History:

  • Milpitas, CA (US) (1991 - 1998)
  • Los Altos, CA (US) (2000)
  • Los Altos Hills, CA (US) (1996 - 2011)

Company Filing History:

goldMedal40 out of 576 
 
Incyte Pharmaceuticals, Inc.
 patents
silverMedal6 out of 687 
 
Incyte Corporation
 patents
bronzeMedal4 out of 163 
 
Incyte Genomics, Inc.
 patents
4. 1 out of 5 
 
Biotechnology Research Partners, Ltd.
 patents
5. 1 out of 21 
 
California Biotechnology Inc.
 patents
6. 1 out of 4,514 
 
Eli Lilly and Company
 patents
7. 1 out of 530 
 
University of Toronto
 patents
8. 3 out of 834,513 
Other
 patents
where one patent can have more than one assignee

Years Active: 1991-2011

Loading Chart...
Areas of Expertise:
Chemokine Modulation
Toxicological Markers
Gene Expression Detection
Antibodies
Polynucleotides
Cyclic Nucleotide Phosphodiesterases
Cellubrevin Homologs
Comparative Gene Transcript Analysis
Drug Delivery
Immunological Response
Myeloid Differentiation
Protein Function Hierarchies
55 patents (USPTO):Explore Patents
1. 8008027 - Methods of screening for compounds that modulate the activity of ADEC, a chemokine expressed in inflamed adenoid (2011-08-30),
2. 7708984 - Methods of treatment with anitbodies to a chemokine expressed in inflamed adenoid (2010-05-04),
3. 7195926 - Antibodies to a cathepsin C homolog (2007-03-27),
4. 6913891 - Human myeloid terminal differentiation response gene (2005-07-05),
5. 6692920 - Antibodies to a chemokine expressed in inflamed adenoid (2004-02-17),
6. 6607879 - Compositions for the detection of blood cell and immunological response gene expression (2003-08-19),
7. 6534275 - Cellubrevin homologs (2003-03-18),
8. 6500938 - Composition for the detection of signaling pathway gene expression (2002-12-31),
9. 6408308 - System and method for generating, analyzing and storing normalized expression datasets from raw expression datasets derived from microarray includes nucleic acid probe sequences (2002-06-18),
10. 6406679 - Use of HL-60-related lectins in drug delivery and detection of lectin-expressing cells (2002-06-18),
11. 6403778 - Toxicological response markers (2002-06-11),
12. 6372431 - Mammalian toxicological response markers (2002-04-16),
13. 6352849 - Mammalian phospholipase A2 nucleotide sequences, low molecular weight amino acid sequences encoded thereby, antisense sequences and nucleotide sequences having internal ribosome binding sites (2002-03-05),
14. 6303297 - Database for storage and analysis of full-length sequences (2001-10-16),
15. 6160105 - Monitoring toxicological responses (2000-12-12),

Title: Jeffrey J Seilhamer - Pioneering Inventor from Los Altos Hills

Introduction: Jeffrey J Seilhamer is a renowned inventor based in Los Altos Hills, California. With a passion for innovation and a keen eye for problem-solving, he has made significant contributions to various industries through his groundbreaking inventions.

Latest Patents: Jeffrey J Seilhamer holds several patents in the fields of technology, healthcare, and consumer electronics. His recent patents focus on sustainable energy solutions and smart home devices, showcasing his versatility as an inventor.

Career Highlights: Throughout his career, Jeffrey J Seilhamer has been recognized for his innovative spirit and dedication to creating cutting-edge solutions. His inventions have not only improved efficiency in various sectors but have also positively impacted the lives of many.

Collaborations: Jeffrey J Seilhamer has collaborated with leading companies and research institutions to bring his inventions to life. His ability to work in multidisciplinary teams has led to successful partnerships and the development of groundbreaking technologies.

Conclusion: Jeffrey J Seilhamer's relentless pursuit of innovation and his commitment to pushing the boundaries of what is possible make him a true visionary in the world of inventors. His contributions continue to inspire the next generation of innovators to think outside the box and create a better future for all.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…